These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [What is your diagnosis? Lobular carcinoma in situ (LCIS) in sclerosing adenosis]. Zámecník M Cesk Patol; 2003 Oct; 39(4):174, 195. PubMed ID: 14663928 [No Abstract] [Full Text] [Related]
3. Carcinoma in situ involving sclerosing adenosis: a mimic of invasive breast carcinoma. Rasbridge SA; Millis RR Histopathology; 1995 Sep; 27(3):269-73. PubMed ID: 8522292 [TBL] [Abstract][Full Text] [Related]
4. Breast procedures guided by magnetic resonance imaging. David J; Trop I; Lalonde L Can Assoc Radiol J; 2005 Dec; 56(5):309-18. PubMed ID: 16579025 [No Abstract] [Full Text] [Related]
5. Lobular neoplasia of the breast revisited with emphasis on the role of E-cadherin immunohistochemistry. Wells JM; Pipa J; Shin SJ Am J Surg Pathol; 2014 Mar; 38(3):434-5. PubMed ID: 24441664 [No Abstract] [Full Text] [Related]
6. The role of fine-needle aspiration cytology and core biopsy in the diagnosis of proliferative and atypical breast lesions. Maygarden SJ Anat Pathol; 1997; 2():165-96. PubMed ID: 9575375 [No Abstract] [Full Text] [Related]
7. Carcinoma In Situ Involving Sclerosing Adenosis: Seeking the Salient Histological Characteristics to Prevent Overdiagnosis. Cui X; Wei S Ann Clin Lab Sci; 2017 Sep; 47(5):529-534. PubMed ID: 29066477 [TBL] [Abstract][Full Text] [Related]
8. Invasive lobular carcinoma in a patient with synchronous ductal carcinoma in situ: detection with MR imaging. Cooney BS; Orel SG; Schnall MD; Troupin RH AJR Am J Roentgenol; 1994 Jun; 162(6):1318-20. PubMed ID: 8191990 [No Abstract] [Full Text] [Related]
11. Occasional FDG PET recognition of in situ breast cancer. Vincenzi B; Calvieri A; Santini D; Altomare V; Tonini G Ann Oncol; 2007 Sep; 18(9):1584-5. PubMed ID: 17761715 [No Abstract] [Full Text] [Related]
12. Management of lobular carcinoma in situ and ductal carcinoma in situ of the breast. Wood WC Semin Oncol; 1996 Aug; 23(4):446-52. PubMed ID: 8757271 [TBL] [Abstract][Full Text] [Related]
13. Cancer upgrades at excisional biopsy after diagnosis of atypical lobular hyperplasia or lobular carcinoma in situ at core-needle biopsy: some reasons why. Cohen MA Radiology; 2004 Jun; 231(3):617-21. PubMed ID: 15163803 [No Abstract] [Full Text] [Related]
14. Adenosis tumor of the breast containing ductal carcinoma in situ, a pitfall in core needle biopsy. Westenend PJ; Liem SJ Breast J; 2001; 7(3):200-1. PubMed ID: 11469938 [No Abstract] [Full Text] [Related]
15. Lobular carcinoma in situ of the breast presenting as a mass. Stein LF; Zisman G; Rapelyea JA; Schwartz AM; Abell B; Brem RF AJR Am J Roentgenol; 2005 Jun; 184(6):1799-801. PubMed ID: 15908533 [No Abstract] [Full Text] [Related]
16. [Therapeutic problems posed by sub-clinical breast cancers]. Espié M Contracept Fertil Sex; 1999 Apr; 27(4):298-305. PubMed ID: 10349773 [TBL] [Abstract][Full Text] [Related]
18. Atypical lobular hyperplasia of the breast: a study of pathologists' responses in the College of American Pathologists Performance Improvement Program in Surgical Pathology. Fitzgibbons PL Arch Pathol Lab Med; 2000 Mar; 124(3):463-4. PubMed ID: 10705409 [No Abstract] [Full Text] [Related]
19. Mammography and ultrasound in the diagnosis of contralateral breast cancer. Rissanen TJ; Mäkäräinen HP; Apaja-Sarkkinen MA; Lindholm EL Acta Radiol; 1995 Jul; 36(4):358-66. PubMed ID: 7619612 [TBL] [Abstract][Full Text] [Related]
20. The management of lobular carcinoma in situ (LCIS). Is LCIS the same as ductal carcinoma in situ (DCIS)? Lakhani SR; Audretsch W; Cleton-Jensen AM; Cutuli B; Ellis I; Eusebi V; Greco M; Houslton RS; Kuhl CK; Kurtz J; Palacios J; Peterse H; Rochard F; Rutgers E; Eur J Cancer; 2006 Sep; 42(14):2205-11. PubMed ID: 16876991 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]